Results 171 to 180 of about 272,684 (347)
ABSTRACT Background Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and ‐modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents.
Femke Lieten+8 more
wiley +1 more source
Relative Fat Mass and Psoriasis Risk: Evidence from NHANES 2009-2014. [PDF]
Ma T, Xiang X, Liu G.
europepmc +1 more source
SALICIN AND SALICYLATES IN THE TREATMENT OF PSORIASIS AND SOME OTHER SKIN AFFECTIONS.1 [PDF]
H. Radcliffe Crocker
openalex +1 more source
ABSTRACT Background Effective management of scalp psoriasis needs treatment with high patient preference and treatment satisfaction. Clinical trials show promising results for calcipotriene and betamethasone dipropionate cream based on polyaphron dispersion (PAD) technology (CAL/BDP PAD‐cream). However, real‐world data are scarce.
Andreas Pinter+6 more
wiley +1 more source
Identification of STAT3 and BIRC5 as anoikis-related biomarkers in psoriasis. [PDF]
Bai W+6 more
europepmc +1 more source